Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 10 Mar 2023
New findings from researchers at Wake Forest University School of Medicine show that the rate of type 1 and type 2 diabetes is increasing...
Read Full NewsAI models have not outperformed existing clinical scores for COPD prognosis, but home monitoring may help track disease activity, Bourbeau said.
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
Williams, MD, is joined by Marcus Gates, MD, and they discuss recognizing cervical nerve root and spinal cord compression, navigating treatment options, and determining when surgery may be appropriate.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 6, 2026.
Two-year data from the phase 2 DAZALS trial showed a lower risk of death with dazucorilant 300 mg/day vs placebo in ALS, although the study did not meet its functional primary end point.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the 2026 AHA/ASA Guideline for Adult Stroke Rehabilitation and Recovery!
Newly presented biomarker and clinical findings from the phase 2b PARADIGM trial of PrimeC informed the design of the global phase 3 PARAGON trial in ALS.
1.
According to JAMA, statin use may increase cancer-related survival in breast cancer patients.
2.
Breast cancer prevention: How nurse practitioners and physician assistants can help
3.
Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC
4.
Pollution exposure may affect lung cancer in women who have never smoked
5.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
1.
Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment
2.
Drug Safety Surveillance for Emerging Immuno-Oncology Medication Risks
3.
Therapeutic Advances in Cancer-Associated Fibroblast Reprogramming
4.
Community Strategies for Improving Early Detection of Blood Disorders
5.
Finding Support: Connecting with the Vitiligo Community
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
4.
Nutrition During Cancer Treatment
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge